{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-001038","form_type":"8-K","ticker":"PAHC","cik":"0001069899","company_name":"PHIBRO ANIMAL HEALTH CORP","filed_at":"2023-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.770506+00:00","generated_at":"2026-06-19T21:24:51.202511+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Phibro Animal Health Q2 net income down 59% to $7.2M; guidance lowered on environmental costs","bullets":["Net sales $244.6M (+5% YoY); GAAP diluted EPS $0.18 vs $0.43 prior; adjusted diluted EPS $0.34 vs $0.37.","Adjusted EBITDA $30.9M (+6% YoY); Animal Health segment grew 9% while Mineral Nutrition declined 8%.","Recorded $6.6M environmental remediation cost from tentative settlement of California contamination lawsuit.","Updated FY23 guidance: Net income lowered to $34-38M (from $39-43M); adjusted metrics unchanged.","Free cash flow -$45M over trailing 12 months due to inventory build to mitigate supply chain risk."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-001038","json":"https://secwatch.observer/filing/0001558370-23-001038.json","markdown":"https://secwatch.observer/filing/0001558370-23-001038.md","text":"https://secwatch.observer/filing/0001558370-23-001038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069899/000155837023001038/0001558370-23-001038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069899/000155837023001038/pahc-20230208x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T21:24:51.202511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba18dbb622c3b4f84bc45c6063568f675390c6d2","claim":"PHIBRO ANIMAL HEALTH CORP reported financial results for the fiscal quarter ended December 31, 2022.","evidence_excerpt":"On February 8, 2023, Phibro Animal Health Corporation issued a press release announcing its operating results for the fiscal quarter ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1069899/000155837023001038/0001558370-23-001038-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter ended December 31, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}